# Post Market Clinical Follow-up Study for the Pamira ICD Lead Family

Study · id `cardio:ct-nct05621187` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05621187](<https://clinicaltrials.gov/study/NCT05621187>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05621187

Browse, organ or system: Heart  
Browse, condition area: Heart rhythm problems; Heart failure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 221 participants.

## Technical summary

Registry record NCT05621187. Allocation not applicable; no masking; primary purpose other. Start 2022-11-30 (actual); primary completion 2025-01-20 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose other
- Phase: Not applicable
- Enrolled: 221 participants (enrolled count; ClinicalTrials.gov record NCT05621187, source copy `cardio:ctgov-nct05621187-2025-02-26`, retrieved 2026-10-26)
- Started: 2022-11-30 (actual) (ClinicalTrials.gov record NCT05621187, source copy `cardio:ctgov-nct05621187-2025-02-26`, retrieved 2026-10-26)
- Primary completion: 2025-01-20 (actual) (ClinicalTrials.gov record NCT05621187, source copy `cardio:ctgov-nct05621187-2025-02-26`, retrieved 2026-10-26)
- Completion: 2025-01-20 (actual) (ClinicalTrials.gov record NCT05621187, source copy `cardio:ctgov-nct05621187-2025-02-26`, retrieved 2026-10-26)
- Countries: Australia; Austria; Belgium; Germany; Hungary; Israel; Latvia; Slovakia (ClinicalTrials.gov record NCT05621187, source copy `cardio:ctgov-nct05621187-2025-02-26`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05621187-2025-02-26`, retrieved 2026-10-26)

## The registry's words

- Brief title: Post Market Clinical Follow-up Study for the Pamira ICD Lead Family
- Condition: Heart Failure
- Condition: Tachyarrhythmia
- Intervention (Device): Pamira ICD lead family
- Lead sponsor: Biotronik SE & Co. KG
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry lists this organization as the lead sponsor: Biotronik SE & Co. KG (`cardio:org-biotronik-se-co-kg`)

## Provenance

Content hash: 76d5d842d026e19bd1c06fec3c23d77cb173e8c5c54ed343ddb00c0e038c784c
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
